133 related articles for article (PubMed ID: 37126833)
21. Multicentric GCT of tarsal bones in an immature skeleton: a case report with review of literature.
Varshney A; Rao H; Sadh R
J Foot Ankle Surg; 2010; 49(4):399.e1-4. PubMed ID: 20554225
[TBL] [Abstract][Full Text] [Related]
22. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
23. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study.
Vult von Steyern F; Bauer HC; Trovik C; Kivioja A; Bergh P; Holmberg Jörgensen P; Follerås G; Rydholm A;
J Bone Joint Surg Br; 2006 Apr; 88(4):531-5. PubMed ID: 16567792
[TBL] [Abstract][Full Text] [Related]
24. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
Perrin DL; Visgauss JD; Wilson DA; Griffin AM; Abdul Razak AR; Ferguson PC; Wunder JS
Bone Joint J; 2021 Jan; 103-B(1):184-191. PubMed ID: 33380180
[TBL] [Abstract][Full Text] [Related]
25. Denosumab for Bone Giant Cell Tumor of the Distal Radius.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Ciani G; Righi A; Akahane M; Honoki K; Tanaka Y; Donati DM; Errani C
Orthopedics; 2020 Sep; 43(5):284-291. PubMed ID: 32745221
[TBL] [Abstract][Full Text] [Related]
26. Giant cell tumor of long bone: a Canadian Sarcoma Group study.
Turcotte RE; Wunder JS; Isler MH; Bell RS; Schachar N; Masri BA; Moreau G; Davis AM;
Clin Orthop Relat Res; 2002 Apr; (397):248-58. PubMed ID: 11953616
[TBL] [Abstract][Full Text] [Related]
27. Impact severity of local recurrence in giant cell tumor of bone.
McGough RL; Rutledge J; Lewis VO; Lin PP; Yasko AW
Clin Orthop Relat Res; 2005 Sep; 438():116-22. PubMed ID: 16131879
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
Tse LF; Wong KC; Kumta SM; Huang L; Chow TC; Griffith JF
Bone; 2008 Jan; 42(1):68-73. PubMed ID: 17962092
[TBL] [Abstract][Full Text] [Related]
29. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
30. Use of extended curettage with osteotomy and fenestration followed by reconstruction with conservation of muscle insertion in the treatment of Enneking stage II locally aggressive bone tumor of the proximal extremities: resection and treatment of bone tumors.
Chen F; Xia J; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J
World J Surg Oncol; 2013 Mar; 11():54. PubMed ID: 23497479
[TBL] [Abstract][Full Text] [Related]
31. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
[TBL] [Abstract][Full Text] [Related]
32. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
Cao W; Ye Z; Lin N; Liu M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
[TBL] [Abstract][Full Text] [Related]
33. An Arthroscopic Approach for the Intralesional Curettage of Giant Cell Tumor of the Distal Femur: A Case Report.
Nugraha HK; Wiratnaya IGE; Astawa P
Oncology (Williston Park); 2023 May; 37(5):204-207. PubMed ID: 37216634
[TBL] [Abstract][Full Text] [Related]
34. [Case analysis on treatment and recurrence of giant cell tumor of bone].
Zhang Z; Zhu B; Sun T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
[TBL] [Abstract][Full Text] [Related]
35. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
[TBL] [Abstract][Full Text] [Related]
37. [Giant-cell tumor of the hand: midterm results in five patients].
Ozalp T; Yercan H; Okçu G; Ozdemir O; Coskunol E; Bégué T; Calli I
Rev Chir Orthop Reparatrice Appar Mot; 2007 Dec; 93(8):842-7. PubMed ID: 18166957
[TBL] [Abstract][Full Text] [Related]
38. Management of pelvic giant cell tumours involving the acetabular bone.
Donati D; Wafa H; Di Bella C; Colangeli M; Colangeli S; Bertoni F
Acta Orthop Belg; 2008 Dec; 74(6):773-8. PubMed ID: 19205324
[TBL] [Abstract][Full Text] [Related]
39. Metachronous multicentric giant-cell tumour: a case report.
Sadat-Ali M
Indian J Cancer; 1997 Dec; 34(4):169-76. PubMed ID: 9715540
[TBL] [Abstract][Full Text] [Related]
40. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
